Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Surgery Partners, Inc. (SGRY)
|
Add to portfolio |
|
|
|
| Price: |
$43.24
| | Metrics |
| OS: |
126.0
|
M
| |
-3
|
% ROE
|
| Market cap: |
$5.45
|
B
| |
|
% ROIC
|
|
Net debt:
|
$2.35
|
B
| |
5.1
|
x Debt/EBITDA
|
|
EV:
|
$7.8
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$459
|
M
| |
17.0
|
x EV/EBITDA
|
|
EBIT
|
$325
|
M
| |
24.0
|
x EV/EBIT
|
| EPS |
($0.94)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 2,539.3 | 2,225.1 | 1,860.1 | 1,831.4 | 1,771.5 | 1,341.2 | 1,145.4 | 959.9 |
| Revenue growth | 14.1% | 19.6% | 1.6% | 3.4% | 32.1% | 17.1% | 19.3% | 138.0% |
| Cost of goods sold | 746.4 | 644.3 | 550.3 | 550.0 | 534.7 | 1,013.8 | 821.2 | 669.3 |
| Gross profit | 1,792.9 | 1,580.8 | 1,309.8 | 1,281.4 | 1,236.8 | 327.4 | 324.2 | 290.6 |
| Gross margin | 70.6% | 71.0% | 70.4% | 70.0% | 69.8% | 24.4% | 28.3% | 30.3% |
| Selling, general and administrative | | | | | | | | 409.5 |
| General and administrative | 1,081.1 | 970.4 | 826.9 | 751.3 | 729.4 | 76.0 | 462.8 | 56.0 |
| EBITA | 353.2 | 333.4 | 244.0 | 267.4 | 188.8 | 164.7 | 231.2 | 169.1 |
| EBITA margin | 13.9% | 15.0% | 13.1% | 14.6% | 10.7% | 12.3% | 20.2% | 17.6% |
| Amortization of intangibles | 6.4 | 6.9 | 4.8 | 4.6 | 4.9 | | 9.6 | 9.1 |
| EBIT | 346.8 | 326.5 | 239.2 | 262.8 | 183.9 | 164.7 | 221.7 | 160.1 |
| EBIT margin | 13.7% | 14.7% | 12.9% | 14.3% | 10.4% | 12.3% | 19.4% | 16.7% |
| Pre-tax income | 110.3 | 81.2 | -18.8 | 54.6 | -69.2 | 82.3 | 92.2 | -76.1 |
| Income taxes | 23.3 | 10.5 | -20.1 | 9.5 | 26.4 | 53.6 | 7.1 | -149.0 |
| Tax rate | 21.1% | 12.9% | 106.9% | 17.4% | | 65.1% | 7.7% | 195.7% |
| Net income | -54.6 | -81.2 | -155.6 | -110.5 | -238.1 | -53.0 | 9.5 | 1.4 |
| Net margin | -2.2% | -3.6% | -8.4% | -6.0% | -13.4% | -4.0% | 0.8% | 0.1% |
| |
| Diluted EPS | ($0.59) | ($1.12) | ($3.19) | ($2.29) | ($4.96) | ($1.10) | $0.20 | $0.04 |
| Shares outstanding (diluted) | 92.0 | 72.4 | 48.8 | 48.3 | 48.0 | 48.2 | 48.2 | 37.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|